(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide
- CAS No.
- 1038915-64-8
- Chemical Name:
- (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide
- Synonyms
- CS-787;Zejula;EOS-62286;MK-4827 (HCl);MK-4827 (hydrochloride);Niraparib hydrochloride;Niraparib HCl (MK-4827);MK-4827, Niraparib HCl salt;Niraparib Tosylate Monohydrate;Niraparib(MK4827) hydrochloride
- CBNumber:
- CB42553458
- Molecular Formula:
- C19H20N4O
- Molecular Weight:
- 320.3883
- MDL Number:
- MFCD20502397
- MOL File:
- 1038915-64-8.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| Niraparib(hydrochloride) 99.80% | CS-2282 | 5mg | $70 |
| MK-4827hydrochloride | B1163 | 5mg | $95 |
| Niraparib(hydrochloride) 99.80% | CS-2282 | 10mg | $100 |
| MK-4827hydrochloride | B1163 | 10mg | $168 |
| Niraparib(hydrochloride) 99.80% | CS-2282 | 50mg | $180 |
| More product size | |||
| Melting point | 144 °C |
|---|---|
| storage temp. | Store at -20°C |
| solubility | Soluble in DMSO |
| form | Solid |
| color | White to light yellow |
| InChI | InChI=1/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/s3 |
| InChIKey | PCHKPVIQAHNQLW-WDHUHKLTNA-N |
| SMILES | N1=C2C(C=CC=C2C(N)=O)=CN1C1=CC=C([C@@H]2CCCNC2)C=C1 |&1:16,r| |
| NCI Dictionary of Cancer Terms | niraparib tosylate monohydrate; Zejula |
| FDA UNII | L4JFC1PHCI |
| NCI Drug Dictionary | niraparib tosylate monohydrate |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P264-P270-P301+P312-P330-P501-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405 |
(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-2282 | Niraparib(hydrochloride) 99.80% | 1038915-64-8 | 5mg | $70 | 2021-12-16 | Buy |
| ApexBio Technology | B1163 | MK-4827hydrochloride | 1038915-64-8 | 5mg | $95 | 2021-12-16 | Buy |
| ChemScene | CS-2282 | Niraparib(hydrochloride) 99.80% | 1038915-64-8 | 10mg | $100 | 2021-12-16 | Buy |
| ApexBio Technology | B1163 | MK-4827hydrochloride | 1038915-64-8 | 10mg | $168 | 2021-12-16 | Buy |
| ChemScene | CS-2282 | Niraparib(hydrochloride) 99.80% | 1038915-64-8 | 50mg | $180 | 2021-12-16 | Buy |
(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide Chemical Properties,Uses,Production
Uses
Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity[1][2][3].
in vivo
Niraparib is well tolerated and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer. Niraparib is well tolerated in vivo and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer. Niraparib is characterized by acceptable pharmacokinetics in rats with plasma clearance of 28 (mL/min)/kg, very high volume of distribution (Vdss=6.9 L/kg), long terminal half-life (t1/2=3.4 h), and excellent bioavailability, F = 65%[1]. Niraparib enhances radiation response of p53 mutant Calu-6 tumor in both cases, with the single daily dose of 50 mg/kg being more effective than 25 mg/kg given twice daily[3].
IC 50
PARP-2: 2.1 nM (IC50); PARP-1: 3.8 nM (IC50); V-PARP: 330 nM (IC50); TANK-1: 570 nM (IC50); PARP-3: 1300 nM (IC50)
References
[1] Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85. DOI:10.1021/jm901188v
[2] Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86. DOI:10.18632/oncotarget.2083
[3] Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20. DOI:10.1007/s10637-011-9770-x
[4] Mirza MR, et al. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 Dec 1;375(22):2154-2164. DOI:10.1056/NEJMoa1611310
(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21592 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29822 | 58 |
| Alchem Pharmtech,Inc. | 8485655694 | sales@alchempharmtech.com | United States | 63687 | 58 |
| Shanghai Yingrui Biopharma Co.,Ltd | 21-33585366 | export01@shyrchem.com | CHINA | 1319 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32467 | 58 |
| Hubei Ipure Biology Co., Ltd | +8613367258412 | ada@ipurechemical.com | China | 10236 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
| Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471; | sales@sarms4muscle.com | China | 10473 | 58 |
| Henan Alfa Chemical Co., Ltd | +8615838112936 | sale03@alfachem.cn | China | 9659 | 58 |
View Lastest Price from (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-04-17 | Niraparib hydrochloride
1038915-64-8
|
US $34.00-80.00 / mg | 99.85% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-06-03 | (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide
1038915-64-8
|
US $0.10-0.30 / kg | 1kg | 99% | 20 tons | Zibo Hangyu Biotechnology Development Co., Ltd | |
![]() |
2024-11-26 | Niraparib tosylate
1038915-64-8
|
US $0.00-0.00 / kg | 1kg | 99%, Single impurity<0.1 | 1 ton | Nanjing Fred Technology Co., Ltd |
-

- Niraparib hydrochloride
1038915-64-8
- US $34.00-80.00 / mg
- 99.85%
- TargetMol Chemicals Inc.
-

- (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide
1038915-64-8
- US $0.10-0.30 / kg
- 99%
- Zibo Hangyu Biotechnology Development Co., Ltd
-

- Niraparib tosylate
1038915-64-8
- US $0.00-0.00 / kg
- 99%, Single impurity<0.1
- Nanjing Fred Technology Co., Ltd
1038915-64-8((S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide)Related Search:
1of4





